Compare Stocks
Compare up to four stocks to (NBIX) by adding the symbol or company name.
NBIX
Compare up to three stocks to NBIX by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector | Sector -- | Sector -- | Sector -- |
Industry | Industry | Industry -- | Industry -- | Industry -- |
CEO | CEO | CEO -- | CEO -- | CEO -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year | 1 Year -- | 1 Year -- | 1 Year -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of Jun 03, 2024 | NBIX Neurocrine Biosciences, Inc. | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |